0 Comentários
0 Compartilhamentos
4 Visualizações
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Feed de notícias
- EXPLORAR
-
Páginas
-
Grupos
-
Blogs
-
Fóruns
-
Faça o login para curtir, compartilhar e comentar!
-
Cancer Tumor Profiling Market: How Is Comprehensive Molecular Characterization Creating Treatment Precision?Comprehensive molecular characterization creating precision — cancer tumor profiling encompassing genomic sequencing, transcriptomic analysis, proteomic characterization, and tumor microenvironment assessment enabling comprehensive cancer characterization identifying therapeutic vulnerabilities and predicting treatment response, establishing tumor profiling as essential cancer management...0 Comentários 0 Compartilhamentos 2 Visualizações
-
Cervical Cancer Treatment Market Outlook 2025–2033: Growth, Trends & ForecastMarket Overview The global cervical cancer treatment market size was valued at USD 8.47 billion in 2024 and is expected to grow from USD 8.88 billion in 2025 to USD 12.91 billion by 2033, growing at a CAGR of 4.8% during the forecast period (2025-2033). The global Cervical Cancer Treatment market continues to evolve rapidly, driven by shifting...0 Comentários 0 Compartilhamentos 4KB Visualizações
-
Global Cancer Treatment Market Trends and ForecastThe global healthcare landscape is currently witnessing a transformative shift in oncology, driven by a surge in precision medicine and early diagnostic breakthroughs. As of 2026, the market is characterized by a rapid transition from traditional "one-size-fits-all" chemotherapy toward highly personalized targeted therapies and immunotherapies. This strategic shift is reflected in the robust...0 Comentários 0 Compartilhamentos 811 Visualizações
-
Hadron Therapy Market Expands with Growing Investment in Advanced Cancer Treatment SystemsAccording to the latest market analysis by Future Market Insights (FMI), the global Hadron Therapy Market is entering a transformative growth phase as hospitals, oncology centers, and research institutions increasingly prioritize advanced particle beam radiation technologies for precision cancer treatment, pediatric oncology care, and dose-conformity advantages across...0 Comentários 0 Compartilhamentos 308 Visualizações
-
Nasopharyngeal Cancer Treatment Market Outlook 2031: Rising Adoption of Immunotherapy and Precision Medicine to Drive Market Beyond US$ 1.1 BillionThe global nasopharyngeal cancer treatment market is witnessing significant growth as advancements in oncology therapeutics continue to improve patient outcomes. Nasopharyngeal cancer, a relatively rare malignancy originating in the nasopharynx, has a higher prevalence in certain regions, particularly across Asia-Pacific. Growing awareness regarding early diagnosis, increasing healthcare...0 Comentários 0 Compartilhamentos 22 Visualizações
-
Oncology Drugs Market Outlook 2026–2034 Innovations Driving the Future of Cancer TreatmentThe Oncology Drugs Market is experiencing remarkable growth, driven by the increasing global burden of cancer, continuous advancements in targeted therapies, and expanding adoption of personalized medicine. As healthcare systems worldwide focus on improving cancer survival rates and treatment outcomes, oncology drugs are becoming a cornerstone of modern healthcare and pharmaceutical...0 Comentários 0 Compartilhamentos 147 Visualizações
-
The Role of Anti-PD-1 Antibodies in Cancer Treatment: Market Insights 2034The global healthcare and biotechnology industry is witnessing strong momentum in immunotherapy research, particularly in cancer treatment solutions. Anti-PD-1 antibodies have emerged as a transformative class of immunotherapeutic agents that enhance the immune system’s ability to identify and destroy cancer cells. Growing cancer prevalence, increasing investment in biologics research,...0 Comentários 0 Compartilhamentos 224 Visualizações
-
Anti-Emetic Drugs Market Size, Share and Trends Forecast to 2030According to the latest report published by Data Bridge Market Research, the Anti-Emetic Drugs Market Data Bridge Market Research analyses that the global anti-emetic drugs market which was USD 7,543.13 million in 2022, is expected to reach USD 12,840.23 million by 2030, and is expected to undergo a CAGR of 6.06% during the forecast period of 2023 to 2030 Global market research...0 Comentários 0 Compartilhamentos 145 Visualizações
-
Asia-Pacific Lymphedema Treatment Market Size, Industry Trends, and Growth Forecast to 2033According to the latest report published by Data Bridge Market Research, the Asia Pacific Lymphedema Treatment Market The Asia-Pacific lymphedema treatment market was valued at USD 153.62 million in 2025 and is projected to reach USD 402.64 million by 2033, growing at a CAGR of 12.80% from 2026 to 2033. The market is witnessing steady growth driven by the...0 Comentários 0 Compartilhamentos 155 Visualizações
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Comentários 0 Compartilhamentos 1KB Visualizações
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Comentários 0 Compartilhamentos 1KB Visualizações
-
Europe Lymphedema Treatment Market Size, Industry Trends, and Growth Forecast to 2033According to the latest report published by Data Bridge Market Research, the Europe Lymphedema Treatment Market The Europe lymphedema treatment market was valued at USD 335.74 million in 2025 and is projected to reach USD 617.70 million by 2033, growing at a CAGR of 9.10% from 2026 to 2033. The market is witnessing steady growth driven by the rising prevalence of...0 Comentários 0 Compartilhamentos 217 Visualizações
-
Global Brachytherapy Market to Reach $1.64 Billion by 2032, Growing at 6.97% CAGRMarket Overview The global brachytherapy market size was valued at USD 895.45 million in 2023 and is projected to reach from USD 957.86 million in 2024 to USD 1,642.09 million by 2032, growing at a CAGR of 6.97% during the forecast period (2024–2032). The global Brachytherapy market is witnessing swift transformation driven by new consumer behaviors, increased...0 Comentários 0 Compartilhamentos 4KB Visualizações
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Comentários 0 Compartilhamentos 1KB Visualizações
-
Global CT Simulators Market Growing at 5.4% CAGR Through 2034According to a new report from Intel Market Research, the global Computed Tomography (CT) Simulators market was valued at USD 1.02 billion in 2025 and is projected to reach USD 1.65 billion by 2034, growing at a CAGR of 5.4% during the forecast period (2025–2034). This growth is propelled by the rising global cancer burden, technological advancements in image-guided radiotherapy (IGRT),...0 Comentários 0 Compartilhamentos 1KB Visualizações
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Comentários 0 Compartilhamentos 1KB Visualizações
Páginas impulsionada